HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA

Clinical trials for HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA explained in plain language.

Never miss a new study

Get alerted when new HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA trials appear

Sign up with your email to follow new studies for HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New cholesterol drug tested for patients who Can't tolerate statins

Disease control Completed

This study tested a drug called ETC-1002 for people with high levels of 'bad' LDL cholesterol who cannot take or do not respond well to standard statin medications. For one year, researchers monitored 130 participants to see how safe the drug was and how well it lowered cholester…

Matched conditions: HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA

Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA

Get alerted when new HYPER-LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROLEMIA trials appear

New cholesterol drug tested for patients who Can't tolerate statins